CN Stock MarketDetailed Quotes

603205 Jianerkang Medical

Watchlist
  • 43.75
  • +3.98+10.01%
Not Open Apr 24 15:00 CST
5.25BMarket Cap42.31P/E (TTM)

Jianerkang Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
--642.74M
219.05%721.81M
--159.16M
54.58%295.58M
----
26.92%226.24M
----
12.14%191.21M
82.27%178.25M
--170.51M
Transactional financial assets
--105.13M
----
--150.08M
----
----
----
----
----
----
----
Notes receivable and accounts receivable
--199.63M
-9.84%212.32M
--232.08M
-0.54%205.87M
----
24.50%235.5M
----
24.22%207M
36.33%189.16M
--166.64M
-Notes receivable
--5.47M
-7.14%5.94M
--5.1M
-19.60%6.11M
----
-55.65%6.4M
----
292.21%7.6M
245.26%14.43M
--1.94M
-Accounts receivable
--194.16M
-9.92%206.37M
--226.97M
0.18%199.76M
----
31.12%229.1M
----
21.07%199.39M
29.84%174.73M
--164.7M
Other receivables (including interest and dividends)
--8.12M
26.98%11.48M
--7.67M
-33.74%7.27M
----
164.91%9.04M
----
29.26%10.98M
-43.12%3.41M
--8.49M
-Dividend receivable
----
----
----
----
----
--0
----
----
----
----
-Accrued interest receivable
----
----
----
----
----
--0
----
----
----
----
-Other receivable
----
----
----
-33.74%7.27M
----
164.91%9.04M
----
--10.98M
-43.12%3.41M
----
Advance payment
--7.85M
50.19%9.11M
--7.32M
75.68%5.65M
----
-65.70%6.06M
----
-11.67%3.22M
110.78%17.68M
--3.64M
Inventories
--173.51M
11.29%176.3M
--163.67M
3.73%162.98M
----
-7.06%158.41M
----
5.03%157.11M
7.46%170.44M
--149.58M
Other current assets
--3.18M
-25.18%4.14M
--8.42M
2.26%5.24M
----
-57.67%5.53M
----
154.29%5.12M
1,144.11%13.06M
--2.01M
Total current assets
--1.14B
77.15%1.14B
--728.38M
18.79%682.59M
----
12.02%640.78M
----
14.73%574.64M
39.31%572.01M
--500.88M
Non Current assets
Fixed assets
----
----
----
5.53%360.45M
----
9.75%371.77M
----
--341.55M
6.08%338.74M
----
Constru in process
----
----
----
-68.18%12.44M
----
-31.46%11.9M
----
--39.09M
136.69%17.36M
----
Intangible assets
--58.1M
-2.52%58.41M
--58.79M
-2.44%59.19M
----
-2.39%59.92M
----
-2.58%60.67M
-2.86%61.39M
--62.27M
Long deferred expense
--10.34M
118.93%6.6M
--5.09M
95.52%5.73M
----
44.49%3.02M
----
26.38%2.93M
0.84%2.09M
--2.32M
Deferred tax assets
--23.04M
-0.44%23.02M
--24.54M
1.37%24.18M
----
-10.93%23.12M
----
-1.66%23.86M
6.54%25.96M
--24.26M
Other non current assets
--4.44M
-35.75%1.97M
--1.53M
212.99%2.48M
----
-72.02%3.06M
----
-93.33%793.71K
-19.14%10.93M
--11.89M
Total non current assets
--456.06M
-3.67%455.42M
--462.59M
-0.94%464.47M
----
3.57%472.79M
----
9.91%468.89M
6.20%456.47M
--426.61M
Total assets
45.43%1.6B
42.84%1.59B
10.40%1.19B
9.92%1.15B
--1.1B
8.27%1.11B
--1.08B
12.51%1.04B
22.38%1.03B
--927.49M
Liabilities
Current liabilities
Short term loan
----
----
----
----
----
----
----
-66.68%20.02M
-39.97%30.04M
--60.07M
Transactional financial liabilities
----
----
----
----
----
--488.6K
----
----
----
----
Notes payable and accounts payable
--84.21M
-20.51%103.84M
--112.26M
-7.57%108.12M
----
0.30%130.62M
----
12.37%116.98M
30.46%130.23M
--104.1M
-Accounts payable
--84.21M
-20.51%103.84M
--112.26M
-7.57%108.12M
----
0.30%130.62M
----
12.37%116.98M
30.46%130.23M
--104.1M
Contract liabilities
--5.27M
49.87%6.48M
--11.83M
5.27%6.2M
----
-51.13%4.32M
----
-22.40%5.88M
92.74%8.85M
--7.58M
Salaries payable
--13.95M
-8.73%17.06M
--14.65M
11.52%15.15M
----
-15.73%18.69M
----
2.99%13.58M
39.15%22.18M
--13.19M
Taxs payable
--5.97M
-49.49%5.24M
--7.88M
-4.44%6.29M
----
5.11%10.38M
----
-46.07%6.58M
180.16%9.87M
--12.2M
Other payable (including interest and dividends)
--1.31M
63.28%1.96M
--1.1M
-28.25%1.11M
----
5.37%1.2M
----
47.13%1.55M
-11.13%1.14M
--1.05M
-Interest payable
----
----
----
----
----
--0
----
----
----
----
-Dividend payable
----
----
----
----
----
--0
----
----
----
----
-Other payable
----
----
----
-28.25%1.11M
----
5.37%1.2M
----
--1.55M
-11.13%1.14M
----
Other current liabilities
--220.73K
71.28%158.88K
--264.38K
-26.60%120.39K
----
-89.44%92.76K
----
-32.61%164.02K
316.41%878.36K
--243.41K
Total current liabilities
--110.93M
-18.73%134.74M
--147.99M
-16.85%136.99M
----
-18.41%165.79M
----
-16.98%164.75M
15.83%203.19M
--198.44M
Current liabilities
Deferred tax liabilities
--1.16M
458.87%1.06M
--614.56K
223.70%621.7K
----
-2.81%189.32K
----
8.61%192.06K
-2.73%194.8K
--176.83K
Long term deferred income
--33.78M
-9.40%34.64M
--35.58M
-8.87%36.46M
----
-8.52%38.24M
----
-8.21%40.01M
-12.49%41.8M
--43.59M
Total non current liabilities
--34.94M
-7.10%35.7M
--36.19M
-7.76%37.09M
----
-8.49%38.43M
----
-8.14%40.21M
-12.45%41.99M
--43.77M
Total liabilities
-9.78%145.86M
-16.54%170.43M
-11.85%184.19M
-15.07%174.07M
--161.68M
-16.71%204.22M
--208.95M
-15.38%204.96M
9.76%245.18M
--242.21M
Shareholders equity
Paid-in capital
--120M
33.33%120M
--90M
0.00%90M
----
0.00%90M
----
0.00%90M
0.00%90M
--90M
Capital reserve funds
--712.11M
102.98%710.69M
--354.1M
0.89%352.82M
----
0.72%350.13M
----
2.32%349.69M
2.63%347.62M
--341.77M
Surplus reserve funds
--55.41M
23.70%55.41M
--44.8M
41.47%44.8M
----
41.47%44.8M
----
81.49%31.67M
81.49%31.67M
--17.45M
Retained profit
--562.83M
25.82%534.03M
--517.88M
32.18%485.37M
----
35.16%424.42M
----
55.55%367.21M
83.75%314.01M
--236.07M
Other composite income
---632.88
---1.82
----
----
----
----
----
----
----
----
Shareholders equity without minority interests
--1.45B
56.17%1.42B
--1.01B
16.03%972.98M
----
16.09%909.35M
----
22.37%838.57M
26.94%783.29M
--685.29M
Total shareholder equity
54.96%1.45B
56.17%1.42B
15.75%1.01B
16.03%972.98M
--935.94M
16.09%909.35M
--869.8M
22.37%838.57M
26.94%783.29M
--685.29M
Total liabilityies and equity
45.43%1.6B
42.84%1.59B
10.40%1.19B
9.92%1.15B
--1.1B
8.27%1.11B
--1.08B
12.51%1.04B
22.38%1.03B
--927.49M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Unqualified opinion
--
Auditor
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
(Q3)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds --642.74M219.05%721.81M--159.16M54.58%295.58M----26.92%226.24M----12.14%191.21M82.27%178.25M--170.51M
Transactional financial assets --105.13M------150.08M----------------------------
Notes receivable and accounts receivable --199.63M-9.84%212.32M--232.08M-0.54%205.87M----24.50%235.5M----24.22%207M36.33%189.16M--166.64M
-Notes receivable --5.47M-7.14%5.94M--5.1M-19.60%6.11M-----55.65%6.4M----292.21%7.6M245.26%14.43M--1.94M
-Accounts receivable --194.16M-9.92%206.37M--226.97M0.18%199.76M----31.12%229.1M----21.07%199.39M29.84%174.73M--164.7M
Other receivables (including interest and dividends) --8.12M26.98%11.48M--7.67M-33.74%7.27M----164.91%9.04M----29.26%10.98M-43.12%3.41M--8.49M
-Dividend receivable ----------------------0----------------
-Accrued interest receivable ----------------------0----------------
-Other receivable -------------33.74%7.27M----164.91%9.04M------10.98M-43.12%3.41M----
Advance payment --7.85M50.19%9.11M--7.32M75.68%5.65M-----65.70%6.06M-----11.67%3.22M110.78%17.68M--3.64M
Inventories --173.51M11.29%176.3M--163.67M3.73%162.98M-----7.06%158.41M----5.03%157.11M7.46%170.44M--149.58M
Other current assets --3.18M-25.18%4.14M--8.42M2.26%5.24M-----57.67%5.53M----154.29%5.12M1,144.11%13.06M--2.01M
Total current assets --1.14B77.15%1.14B--728.38M18.79%682.59M----12.02%640.78M----14.73%574.64M39.31%572.01M--500.88M
Non Current assets
Fixed assets ------------5.53%360.45M----9.75%371.77M------341.55M6.08%338.74M----
Constru in process -------------68.18%12.44M-----31.46%11.9M------39.09M136.69%17.36M----
Intangible assets --58.1M-2.52%58.41M--58.79M-2.44%59.19M-----2.39%59.92M-----2.58%60.67M-2.86%61.39M--62.27M
Long deferred expense --10.34M118.93%6.6M--5.09M95.52%5.73M----44.49%3.02M----26.38%2.93M0.84%2.09M--2.32M
Deferred tax assets --23.04M-0.44%23.02M--24.54M1.37%24.18M-----10.93%23.12M-----1.66%23.86M6.54%25.96M--24.26M
Other non current assets --4.44M-35.75%1.97M--1.53M212.99%2.48M-----72.02%3.06M-----93.33%793.71K-19.14%10.93M--11.89M
Total non current assets --456.06M-3.67%455.42M--462.59M-0.94%464.47M----3.57%472.79M----9.91%468.89M6.20%456.47M--426.61M
Total assets 45.43%1.6B42.84%1.59B10.40%1.19B9.92%1.15B--1.1B8.27%1.11B--1.08B12.51%1.04B22.38%1.03B--927.49M
Liabilities
Current liabilities
Short term loan -----------------------------66.68%20.02M-39.97%30.04M--60.07M
Transactional financial liabilities ----------------------488.6K----------------
Notes payable and accounts payable --84.21M-20.51%103.84M--112.26M-7.57%108.12M----0.30%130.62M----12.37%116.98M30.46%130.23M--104.1M
-Accounts payable --84.21M-20.51%103.84M--112.26M-7.57%108.12M----0.30%130.62M----12.37%116.98M30.46%130.23M--104.1M
Contract liabilities --5.27M49.87%6.48M--11.83M5.27%6.2M-----51.13%4.32M-----22.40%5.88M92.74%8.85M--7.58M
Salaries payable --13.95M-8.73%17.06M--14.65M11.52%15.15M-----15.73%18.69M----2.99%13.58M39.15%22.18M--13.19M
Taxs payable --5.97M-49.49%5.24M--7.88M-4.44%6.29M----5.11%10.38M-----46.07%6.58M180.16%9.87M--12.2M
Other payable (including interest and dividends) --1.31M63.28%1.96M--1.1M-28.25%1.11M----5.37%1.2M----47.13%1.55M-11.13%1.14M--1.05M
-Interest payable ----------------------0----------------
-Dividend payable ----------------------0----------------
-Other payable -------------28.25%1.11M----5.37%1.2M------1.55M-11.13%1.14M----
Other current liabilities --220.73K71.28%158.88K--264.38K-26.60%120.39K-----89.44%92.76K-----32.61%164.02K316.41%878.36K--243.41K
Total current liabilities --110.93M-18.73%134.74M--147.99M-16.85%136.99M-----18.41%165.79M-----16.98%164.75M15.83%203.19M--198.44M
Current liabilities
Deferred tax liabilities --1.16M458.87%1.06M--614.56K223.70%621.7K-----2.81%189.32K----8.61%192.06K-2.73%194.8K--176.83K
Long term deferred income --33.78M-9.40%34.64M--35.58M-8.87%36.46M-----8.52%38.24M-----8.21%40.01M-12.49%41.8M--43.59M
Total non current liabilities --34.94M-7.10%35.7M--36.19M-7.76%37.09M-----8.49%38.43M-----8.14%40.21M-12.45%41.99M--43.77M
Total liabilities -9.78%145.86M-16.54%170.43M-11.85%184.19M-15.07%174.07M--161.68M-16.71%204.22M--208.95M-15.38%204.96M9.76%245.18M--242.21M
Shareholders equity
Paid-in capital --120M33.33%120M--90M0.00%90M----0.00%90M----0.00%90M0.00%90M--90M
Capital reserve funds --712.11M102.98%710.69M--354.1M0.89%352.82M----0.72%350.13M----2.32%349.69M2.63%347.62M--341.77M
Surplus reserve funds --55.41M23.70%55.41M--44.8M41.47%44.8M----41.47%44.8M----81.49%31.67M81.49%31.67M--17.45M
Retained profit --562.83M25.82%534.03M--517.88M32.18%485.37M----35.16%424.42M----55.55%367.21M83.75%314.01M--236.07M
Other composite income ---632.88---1.82--------------------------------
Shareholders equity without minority interests --1.45B56.17%1.42B--1.01B16.03%972.98M----16.09%909.35M----22.37%838.57M26.94%783.29M--685.29M
Total shareholder equity 54.96%1.45B56.17%1.42B15.75%1.01B16.03%972.98M--935.94M16.09%909.35M--869.8M22.37%838.57M26.94%783.29M--685.29M
Total liabilityies and equity 45.43%1.6B42.84%1.59B10.40%1.19B9.92%1.15B--1.1B8.27%1.11B--1.08B12.51%1.04B22.38%1.03B--927.49M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion----Unqualified opinion--
Auditor --Tianheng Certified Public Accountants (Special General Partnership)------Tianheng Certified Public Accountants (Special General Partnership)----Tianheng Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.61%
Sample Name
Sample Code
 +9.76%
Sample Name
Sample Code
 +9.67%
4
Nu Holdings
NU
+8.80%
5
Liberty Latin America-A
LILA
+8.14%
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs

Investment Course

How to Buy Stocks for Beginners
Learn stock market basics and confidently start investing with our beginner-friendly guide to buying stocks. Start your investment journey today!
What Is Options Trading and How to Trade Options
Options trading is carried out by all kinds of investors within individual investment portfolios. Learn how you can put options to work within your own portfolio.
What To Know About Margin Accounts
Discover the essentials of margin accounts, including their benefits, risks, and how to use them effectively in your trading strategy.
Cash Accounts - Covering the Basics
Discover the essentials of cash accounts. Learn what cash accounts are, how they function, their potential benefits, and the differences between cash and margin accounts.
Understanding Fractional Shares: A Beginner's Guide
Discover the basics of fractional shares, how they work, and the process for buying and selling them.

- No more -